Jackson Square Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Jackson Square Partners's CELG Position: Q1 2018 in Review
Jackson Square Partners sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 5,668,473 shares — an estimated $592M sold.
Jackson Square Partners first reported a position in CELG in Q2 2014 and held it in 15 quarters. The position peaked at $1.41B in Q4 2015. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.
- Jackson Square Partners reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
- Jackson Square Partners sold 5,668,473 Celgene Corp shares in Q1 2018, an estimated $592M.
- Jackson Square Partners first reported a position in Celgene Corp in Q2 2014 and held it in 15 quarters.
- Jackson Square Partners's Celgene Corp position peaked at $1.41B in Q4 2015.
- 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.
Based on Jackson Square Partners's 13F filing for Q1 2018, filed 14 May 2018.